These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2959322)

  • 41. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.
    Dyr JE; Blombäck B; Hessel B; Kornalík F
    Biochim Biophys Acta; 1989 Jan; 990(1):18-24. PubMed ID: 2914147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonrandom catabolism of proteins in the formation of antigenic peptide fragments.
    Thomas DW; Schauster JL; Hoffman MD; Wilner GD
    J Immunol; 1985 Aug; 135(2):1259-63. PubMed ID: 3874235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
    Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
    J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of temperature on the velocity of erythrocyte aggregation.
    Maeda N; Seike M; Shiga T
    Biochim Biophys Acta; 1987 Nov; 904(2):319-29. PubMed ID: 3663676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of bovine fibrinopeptides on the central action of chlorpromazine and amphetamine in rats.
    Buczko W
    Acta Neurobiol Exp (Wars); 1976; 36(4):447-54. PubMed ID: 983820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
    Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Interaction of heavy and light chains of plasmin with fibrinogen E and D fragments].
    Kudinov SA; Lezhen TI
    Biokhimiia; 1984 Dec; 49(12):2003-7. PubMed ID: 6240993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of fibrinopeptides A and B on the circulatory action of dopamine.
    Barczak-Osińska J; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(4):285-92. PubMed ID: 6664936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for four different polymerization sites involved in human fibrin formation.
    Olexa SA; Budzynski AZ
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1374-8. PubMed ID: 6929491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization.
    Ruf W; Bender A; Lane DA; Preissner KT; Selmayr E; Müller-Berghaus G
    Biochim Biophys Acta; 1988 May; 965(2-3):169-75. PubMed ID: 3365451
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The peptide beta 43-47 which increases microvascular permeability is released by plasmin during cleavage of fragment Y of fibrinogen.
    Cierniewski CS; Poniatowski J; Urbanczyk J
    Biochim Biophys Acta; 1986 Dec; 884(3):594-7. PubMed ID: 2946323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Some pharmacological and biochemical effects of fibrinopeptides A and B in the circulatory system of rats.
    Antecka-Genadiew E; Buczko W; Stasiak A; Maciejewski A; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(5):359-66. PubMed ID: 6664938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemotaxis for human monocytes by fibrinogen-derived peptides.
    Richardson DL; Pepper DS; Kay AB
    Br J Haematol; 1976 Apr; 32(4):507-13. PubMed ID: 1259932
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of shear rate on rouleau formation in simple shear flow.
    Murata T; Secomb TW
    Biorheology; 1988; 25(1-2):113-22. PubMed ID: 3196807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of pH on the velocity of erythrocyte aggregation.
    Maeda N; Seike M; Suzuki Y; Shiga T
    Biorheology; 1988; 25(1-2):25-30. PubMed ID: 3196821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Binding of Glu-plasminogen by fibrinogen and byproducts of its proteolysis].
    Grinenko TV; Tret'iachenko VG; Skomorovskaia EV; Kudinov SA
    Biokhimiia; 1989 Feb; 54(2):213-20. PubMed ID: 2525932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.
    Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST
    Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasmic degradation of human fibrinogen. IV. Identification of subunit chain remnants in fragment Y.
    Furlan M; Seelich T; Beck EA
    Biochim Biophys Acta; 1975 Jul; 400(1):112-20. PubMed ID: 125108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.